Bayesian Meta-analysis of Safety Outcomes Using Blinded Clinical Trial Data.
Emily GorenLi-An LinRobert O BlausteinGreg BallPublished in: Therapeutic innovation & regulatory science (2020)
At any time during the drug development program, our approach provides easily interpretable posterior probability statements about the risk ratio for the safety event(s) of interest.